title: Acetylcholine attenuates cardiomyocyte oxidant stress during simulated ischemia and reoxygenation.
abstract: We wanted to determine whether oxygen radicals open the mitochondrial ATP-dependent potassium channels (K(ATP)) during an ischemic period to reduce cell death and oxidant stress. Chick embryonic cardiomyocytes were used. Cell viability was quantified with propidium iodide (5 microM), and free radicals was measured using 2',7'-dichlorofluorescein diacetate. Preconditioning was produced by 10 min of simulated ischemia followed by 10 min of reoxygenation. Acetylcholine (1 mM), infused for 10 min instead of preconditioning, reduced cell death similarly (24 +/- 5%, n = 7 and 18 +/- 2%, n = 7, respectively, vs. controls, 49 +/- 6%, n = 8). In control series, 60 min of simulated ischemia and 3 h of reoxygenation generated free radicals more than 300% above the baseline (ischemia: 3.63 +/- 0.58, reoxygenation: 3.66 +/- 0.47, n = 8). Preconditioning and acetylcholine markedly attenuated the oxidant stress during simulated ischemia (1.18 +/- 0.41, n = 6 and 1.34 +/- 0.60, n = 7 vs. controls 3.63 +/- 0.58, n = 8) and re-oxygenation (1.23 +/- 0.36, n = 6 and 1.50 +/- 0.59, n = 7 vs. controls 3.66 +/- 0.47, n = 8). The protection of acetylcholine was abolished with pretreatment with the antioxidant thiol reductant 2-mercaptopropionyl glycine and posttreatment with 5-hydroxydecanoate, a selective mitochondrial K(ATP) channel antagonist (37 +/- 7%, n = 7). These results demonstrate that oxygen radicals open mitochondrial K(ATP) channels, which mediates the acetylcholine-induced preconditioning effect, and that stimulation of this signaling pathway attenuates oxidant stress.
authors.affiliation: Department of Anesthesia and Critical Care, The University of Chicago, Chicago, IL, USA.
authors.forename: Bradley C
authors.initials: BC
authors.lastname: McPherson
authors.forename: Xiangdong
authors.initials: X
authors.lastname: Zhu
authors.forename: Huiping
authors.initials: H
authors.lastname: Liu
authors.forename: Bin
authors.initials: B
authors.lastname: Wang
authors.forename: Timir
authors.initials: T
authors.lastname: Baman
authors.forename: Steven S
authors.initials: SS
authors.lastname: McPherson
authors.forename: Mark L A
authors.initials: ML
authors.lastname: Da Costa
authors.forename: David V
authors.initials: DV
authors.lastname: Jayakar
authors.forename: Valluvan
authors.initials: V
authors.lastname: Jeevanandam
authors.forename: Zhenhai
authors.initials: Z
authors.lastname: Yao
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology*; D000704:Analysis of Variance; D000818:Animals; D016923:Cell Death; D002645:Chickens; D004347:Drug Interactions; D005609:Free Radicals / Q000378:metabolism*; D019157:Ischemic Preconditioning, Myocardial; D017202:Myocardial Ischemia / Q000188:drug therapy*; D018384:Oxidative Stress / Q000187:drug effects; D015221:Potassium Channels / Q000187:drug effects*; D008625:Tiopronin / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
chemical_list: D005609:Free Radicals; D015221:Potassium Channels; D014665:Vasodilator Agents; D008625:Tiopronin; D000109:Acetylcholine